Synairgen (SNG)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

4.63p
   
  • Change Today:
      0.040p
  • 52 Week High: 9.80p
  • 52 Week Low: 3.40p
  • Currency: UK Pounds
  • Shares Issued: 202.66m
  • Volume: 27,287
  • Market Cap: £9.38m
  • RiskGrade: 510
  • Beta: 1.51

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth Not Available

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio Not Available
Price Book Ratio
43.36% above the market average43.36% above the market average43.36% above the market average43.36% above the market average43.36% above the market average
72.09% above the sector average72.09% above the sector average72.09% above the sector average72.09% above the sector average72.09% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
46.82% above the market average46.82% above the market average46.82% above the market average46.82% above the market average46.82% above the market average
32.00% above the sector average32.00% above the sector average32.00% above the sector average32.00% above the sector average32.00% above the sector average
Price Chg 3m
92.26% above the market average92.26% above the market average92.26% above the market average92.26% above the market average92.26% above the market average
92.00% above the sector average92.00% above the sector average92.00% above the sector average92.00% above the sector average92.00% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
32.13% above the market average32.13% above the market average32.13% above the market average32.13% above the market average32.13% above the market average
26.09% above the sector average26.09% above the sector average26.09% above the sector average26.09% above the sector average26.09% above the sector average
Momentum 20
32.82% above the market average32.82% above the market average32.82% above the market average32.82% above the market average32.82% above the market average
21.74% above the sector average21.74% above the sector average21.74% above the sector average21.74% above the sector average21.74% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin Not Available
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
72.85% below the market average72.85% below the market average72.85% below the market average72.85% below the market average72.85% below the market average
42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover Not Available
Operating Profit Loss
82.77% below the market average82.77% below the market average82.77% below the market average82.77% below the market average82.77% below the market average
55.1% below the sector average55.1% below the sector average55.1% below the sector average55.1% below the sector average55.1% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
20.86% below the market average20.86% below the market average20.86% below the market average20.86% below the market average20.86% below the market average
23.40% above the sector average23.40% above the sector average23.40% above the sector average23.40% above the sector average23.40% above the sector average
Cash
9.49% above the market average9.49% above the market average9.49% above the market average9.49% above the market average9.49% above the market average
22.45% above the sector average22.45% above the sector average22.45% above the sector average22.45% above the sector average22.45% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral
92.40% above the market average92.40% above the market average92.40% above the market average92.40% above the market average92.40% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Synairgen Market Data

Currency UK Pounds
Share Price 4.63p
Change Today 0.040p
% Change 0.87 %
52 Week High 9.80p
52 Week Low 3.40p
Volume 27,287
Shares Issued 202.66m
Market Cap £9.38m
Beta 1.51
RiskGrade 510

Synairgen Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
52.77% above the market average52.77% above the market average52.77% above the market average52.77% above the market average52.77% above the market average
80.00% above the sector average80.00% above the sector average80.00% above the sector average80.00% above the sector average80.00% above the sector average
Price Trend
79.28% below the market average79.28% below the market average79.28% below the market average79.28% below the market average79.28% below the market average
63.27% below the sector average63.27% below the sector average63.27% below the sector average63.27% below the sector average63.27% below the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 0
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 1
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Synairgen Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
15:53 46 @ 4.92p
15:35 3,129 @ 4.40p
15:09 4,000 @ 4.40p
13:55 2,503 @ 4.72p
13:03 8,609 @ 4.40p

Synairgen Key Personnel

CEO Richard J Marsden

Top of Page